8-K - Prelude Therapeutics Incorporated | StockGist

Current Report Details

Event Type

Management Change

Shareholder Vote

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o

Management Change

Dr. Scherer in the form that it has entered into with its other directors and that is filed as Exhibit 10.1 to the Company

5.07

Submission of Matters to a Vote of Security Holders. On June 12, 2025, the Company held its Annual Meeting and the following proposals were adopted: 1. Election

Shareholder Vote

Exhibits (1)

8-K